Today: 11 June 2026
Browse Category

NASDAQ:LRCX 29 December 2025 - 7 January 2026

Lam Research stock jumps nearly 7% on fresh Aletheia “Buy” call as CES focus stays on AI

Lam Research stock jumps nearly 7% on fresh Aletheia “Buy” call as CES focus stays on AI

Lam Research shares jumped 6.9% to $208.15 Tuesday after Aletheia Capital initiated coverage with a buy rating and $260 target. Peers Applied Materials and KLA also rose. Investors await Lam’s Jan. 28 earnings for signals on chip equipment demand and 2026 spending. The rally follows increased focus on AI data-center buildouts and new product launches at CES.
Lam Research stock (LRCX) jumps 5% as CES 2026 AI headlines fuel chip-equipment rally

Lam Research stock (LRCX) jumps 5% as CES 2026 AI headlines fuel chip-equipment rally

Lam Research closed up 5.3% at $194.76 Monday, holding gains after hours as chip-equipment stocks rallied sharply. Applied Materials, KLA, and ASML each rose over 5%, outpacing the semiconductor ETF. Investors tracked CES news and awaited Lam’s Jan. 28 earnings report. Foxconn reported record Q4 revenue on strong AI product demand.
Lam Research stock today: LRCX jumps 8% on Citi list as chip-equipment rally builds

Lam Research stock today: LRCX jumps 8% on Citi list as chip-equipment rally builds

Lam Research shares jumped 8.1% to $185.06 Friday after being added to Citi’s Large Cap Recommended list for 2026, trading as high as $185.78. ASML rose 8.7%, while Applied Materials and KLA each gained nearly 5%. The move came on heavy volume, with Lam’s session low at $177.50 now seen as support. Investors await ISM manufacturing data Jan. 5 and Lam’s dividend Jan. 7.
Lam Research stock jumps 8% to start 2026 as chip-tool shares rally — what LRCX investors watch next

Lam Research stock jumps 8% to start 2026 as chip-tool shares rally — what LRCX investors watch next

Lam Research shares surged 8.1% to $185.06 Friday, leading semiconductor equipment stocks after the U.S. changed licensing rules for chipmaking tool shipments to China. The Philadelphia Semiconductor Index rose about 4%. Investors are watching for further export-rule updates and Lam’s next earnings date, expected in late January or early February.
Lam Research stock hits record after Citi adds LRCX to 2026 list, lifting chip gear peers

Lam Research stock hits record after Citi adds LRCX to 2026 list, lifting chip gear peers

Lam Research shares jumped 8.1% to $185.06 in after-hours trading Friday after Citi added the chip-equipment maker to its 2026 Large Cap Recommended list. The stock set a new intraday high, with gains supported by bullish calls from TD Cowen and Cantor Fitzgerald. Applied Materials and ASML also rose late. Investors are watching for Lam’s next earnings date and any signs of shifting demand in China.
Applied Materials stock drops again as China’s “50% local tools” push weighs on AMAT

Applied Materials stock drops again as China’s “50% local tools” push weighs on AMAT

Applied Materials shares fell 1.1% to $256.99 Wednesday, extending a two-day slide as China moved to require chipmakers to use at least 50% domestic equipment for new semiconductor plants, Reuters reported. Lam Research dropped 1.5% and KLA lost 2.3%. TSMC said it received a U.S. export license for its Nanjing fab, allowing continued equipment shipments. Trading in Applied was light, with the stock closing about 7% below its recent high.
Applied Materials stock snaps 7-day rally as China pushes “50% domestic tools” rule

Applied Materials stock snaps 7-day rally as China pushes “50% domestic tools” rule

Applied Materials shares fell 1.2% to $259.97 Tuesday, ending a seven-day rally. Lam Research and KLA also closed lower. Reuters reported China is requiring chipmakers to source at least half of new-fab equipment from domestic suppliers, raising uncertainty for U.S. toolmakers. U.S. granted Samsung and SK Hynix annual licenses for chip equipment shipments to China.
Lam Research (LRCX) slips after report China tightens “50% domestic tools” push

Lam Research (LRCX) slips after report China tightens “50% domestic tools” push

Lam Research shares fell 1.2% to $173.78 in after-hours trading Tuesday after Reuters reported China now requires chipmakers to source at least 50% of equipment domestically for new capacity approvals. Applied Materials and KLA also declined, while ASML rose. The policy could pressure foreign suppliers like Lam, which derives about 93% of revenue from non-U.S. sales. Investors are watching for details on enforcement and possible waivers.
Applied Materials stock slips as China’s 50% domestic chip-tool rule puts AMAT in the spotlight

Applied Materials stock slips as China’s 50% domestic chip-tool rule puts AMAT in the spotlight

Applied Materials shares fell 1.1% to $260.27 Tuesday after Reuters reported China now requires chipmakers expanding capacity to source at least 50% of equipment domestically. The iShares Semiconductor ETF was little changed. Wells Fargo raised its price target on Applied Materials to $290 and maintained an Overweight rating. Lam Research and KLA shares also slipped about 1%.
KLA stock dips as China’s 50% domestic chip-tool rule rattles semiconductor equipment names

KLA stock dips as China’s 50% domestic chip-tool rule rattles semiconductor equipment names

KLA shares fell 0.8% to $1,250.43 Tuesday after a Reuters report said China will require chipmakers to source at least half of new-fab equipment domestically. U.S. chip-equipment stocks tracked lower as traders awaited Federal Reserve minutes and eyed tightening export-license rules. Applied Materials and Lam Research also declined, while ASML rose.
KLA stock drops after tech pullback hits chip equipment names; Fed minutes next

KLA stock drops after tech pullback hits chip equipment names; Fed minutes next

KLA Corp shares fell 1.5% to $1,260.39 Monday, ending a six-session winning streak as tech stocks retreated in thin year-end trading. The Philadelphia Semiconductor Index dropped 0.41%. KLA’s volume was lighter than usual, with 625,000 shares traded versus a 993,000 average. Investors await Fed minutes and jobless claims later this week.
1 4 5 6 7 8 10

Stock Market Today

  • What is an IPO as SpaceX Prepares for U.S. Stock Market Debut
    June 10, 2026, 6:01 PM EDT. An IPO, or Initial Public Offering, is when a private company sells shares to the public for the first time, becoming publicly traded. SpaceX, the aerospace manufacturer, is expected to make its debut on the U.S. stock market, marking one of the most anticipated IPOs in recent years. This move allows retail and institutional investors to buy equity in SpaceX, potentially impacting the space industry and tech sectors. The IPO process involves regulatory filings, pricing, and public trading, providing companies with capital for expansion. SpaceX's offering could reshape market dynamics, drawing significant investor interest given its innovations and growth trajectory.

Latest articles

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

10 June 2026
Parabilis Medicines soared 58% above its $20 IPO price to close at $31.60 in its Nasdaq debut after raising a record $670 million, reflecting strong investor demand for its Helicon drug platform ahead of a pivotal Phase 3 desmoid tumor trial planned for 2027; Regeneron’s $75 million private placement added credibility.
Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
Go toTop